Drug-Eluting Stent Failure prevention by Aggressive Statin therapy trial

Drug-Eluting Stent Failure prevention by Aggressive Statin therapy trial - Drug-Eluting Stent Failure prevention by Aggressive Statin therapy trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020452

Enrollment

300

Registered

2016-01-18

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

The aggressive statin treatment, targeted at LDL-C &lt

70mg/dl, for 5 years. The standard statin treatment, targeted at LDL-C &lt

100mg/dl, for 5 years

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received PCI with DES.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
Very-late DES failure (cardiac death or TLR) at 5 years	—

Countries

Japan

Contacts

Public ContactYasunori Ueda

National Hospital Organization Osaka National Hospital Cardiovascular Division

ueda.yasunori.ju@mail.hosp.go.jp+81-6-6942-1331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026